Clinical Observation on the Effect of Dexamethasone and Chinese Herbal Decoction for Purgation in Severe Acute Pancreatitis Patients

Objective:To investigate the effect of dexamethasone(Dx) combined with modified Dachengqi Decoction(大承气汤,DCQD),a Chinese herbal decoction for purgation,on patients with severe acute pancreatitis(SAP) accompanied with systematic inflammatory response syndrome(SIRS).Methods:A total of 81 patients diag...

Full description

Saved in:
Bibliographic Details
Published inChinese journal of integrative medicine Vol. 17; no. 3; pp. 141 - 145
Main Author 万美华 李娟 龚翰林 薛平 朱林 陈光远 夏庆 唐文富
Format Journal Article
LanguageEnglish
Published 2011
Subjects
Online AccessGet full text
ISSN1672-0415
1993-0402

Cover

More Information
Summary:Objective:To investigate the effect of dexamethasone(Dx) combined with modified Dachengqi Decoction(大承气汤,DCQD),a Chinese herbal decoction for purgation,on patients with severe acute pancreatitis(SAP) accompanied with systematic inflammatory response syndrome(SIRS).Methods:A total of 81 patients diagnosed as SAP were randomly assigned to a control group or treatment group according to a random number table generated from an SPSS software.The patients in the control group(38 cases) received standard treatment and Chinese herbal decoction for purgation;those in the treatment group(43 cases) received additional 1 mg/(kg·d) dexamethasone(Dx) treatment for three days based on the above treatment.The mortality rate,acute respiratory distress syndrome(ARDS),renal failure,hemorrhage,sepsis,pancreatic pseudocyst, pancreatic abscess,operability,and days of hospitalization were compared between the two groups.Results: Three patients in the control group and eight patients in the treatment group dropped out from the study with a drop-out rate of 7.8%and 18.6%,respectively,and no statistics difference was shown between the two groups (P0.05).Dx treatment significantly reduced ARDS rate and shortened the length of hospitalization compared to those in the control group(7/35,20.0%versus 15/35,42.9%,P=0.0394;32.5±13.2 days versus 40.2±17.5 days,P=0.0344).Other parameters including the mortality rate were not significant different between the two groups.Conclusion:Dx combined with DCQD could decrease the risk of developing ARDS in SAP patients with SIRS and shorten their length of hospitalization.
Bibliography:dexamethasone
severe acute pancreatitis
S858.28
severe acute pancreatitis; systematic inflammatory response syndrome; acute respiratory distress syndrome; dexamethasone; Dachengqi Decoction
systematic inflammatory response syndrome
acute respiratory distress syndrome
Dachengqi Decoction
11-4928/R
S858.237.2
ISSN:1672-0415
1993-0402